ArticleSensors (Basel, Switzerland)2024
Achieving More with Less: A Lightweight Deep Learning Solution for Advanced Human Activity Recognition (HAR).
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DeM-FCN: an ultra-lightweight and purely convolutional framework for edge-native human activity recognition in wearable fitness tracking.Frontiers in sports and active living · 2026Article
- Metaheuristic-Driven Feature Selection for Human Activity Recognition on KU-HAR Dataset Using XGBoost Classifier.Sensors (Basel, Switzerland) · 2025Article
- Multiscale Residual Weighted Classification Network for Human Activity Recognition in Microwave Radar.Sensors (Basel, Switzerland) · 2025Article
- Time-Series Representation Feature Refinement with a Learnable Masking Augmentation Framework in Contrastive Learning.Sensors (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human activity recognition (HAR) is a crucial task in various applications, including healthcare, fitness, and the military. Deep learning models have revolutionized HAR, however, their computational complexity, particularly those involving BiLSTMs, poses significant challenges for deployment on resource-constrained devices like smartphones. While BiLSTMs effectively capture long-term dependencies by processing inputs bidirectionally, their high parameter count and computational demands hinder practical applications in real-time HAR. This study investigates the approximation of the computationally intensive BiLSTM component in a HAR model by using a combination of alternative model components and data flipping augmentation. The proposed modifications to an existing hybrid model architecture replace the BiLSTM with standard and residual LSTM, along with convolutional networks, supplemented by data flipping augmentation to replicate the context awareness typically provided by BiLSTM networks. The results demonstrate that the residual LSTM (ResLSTM) model achieves superior performance while maintaining a lower computational complexity compared to the traditional BiLSTM model. Specifically, on the UCI-HAR dataset, the ResLSTM model attains an accuracy of 96.34% with 576,702 parameters, outperforming the BiLSTM model's accuracy of 95.22% with 849,534 parameters. On the WISDM dataset, the ResLSTM achieves an accuracy of 97.20% with 192,238 parameters, compared to the BiLSTM's 97.23% accuracy with 283,182 parameters, demonstrating a more efficient architecture with minimal performance trade-off. For the KU-HAR dataset, the ResLSTM model achieves an accuracy of 97.05% with 386,038 parameters, showing comparable performance to the BiLSTM model's 98.63% accuracy with 569,462 parameters, but with significantly fewer parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.